Abbott Laboratories buy UBS Group AG
Start price
17.10.24
/
50%
€108.52
Target price
17.10.25
€134.85
Performance (%)
1.35%
End price
18.10.25
€109.98
Summary
This prediction ended on 18.10.25 with a price of €109.98. With a performance of 1.35%, the BUY prediction by UBS_Group_AG for Abbott Laboratories closed with a slight gain. UBS_Group_AG has a follow-up prediction for Abbott Laboratories where he still thinks Abbott Laboratories is a Buy. A total of €0.57 was paid as dividends for this prediction. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Abbott Laboratories | 1.593% | 1.593% | -39.041% |
| iShares Core DAX® | -2,11 % | -1,09 % | 0,19 % |
| iShares Nasdaq 100 | 1,08 % | 13,12 % | 31,86 % |
| iShares Nikkei 225® | -2,21 % | 7,98 % | 44,52 % |
| iShares S&P 500 | 1,60 % | 7,24 % | 21,65 % |
Comments by UBS_Group_AG for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at UBS Group AG from $143.00 to $146.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
In the thread Trading Abbott Laboratories
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Current prediction by UBS_Group_AG for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€81.00
21.04.26
21.04.26
€114.62
21.04.27
21.04.27
-10.25%
15.05.26
15.05.26
Stopped prediction by UBS_Group_AG for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€113.50
23.01.25
23.01.25
€142.08
23.01.26
23.01.26
-19.76%
24.01.26
24.01.26
Abbott Laboratories
Start price
Target price
Perf. (%)
€102.04
20.04.23
20.04.23
€118.42
20.04.24
20.04.24
-1.53%
21.04.24
21.04.24